Leyin Wu

ORCID: 0009-0006-9099-1283
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Stress, Anesthesia, and Immune Response
  • Advanced Breast Cancer Therapies
  • Receptor Mechanisms and Signaling
  • Cancer Cells and Metastasis
  • Hormonal Regulation and Hypertension
  • Bioactive Compounds and Antitumor Agents
  • Genomics, phytochemicals, and oxidative stress

China Pharmaceutical University
2023-2024

Gastric cancer often shows malignant growth and insensitivity to chemotherapeutic drugs due the regulation of complex molecular mechanisms, which results in poor prognosis for patients. However, relevant mechanisms remain unclear. In this study, we reported that family with sequence similarity 117, member B (FAM117B), promoted gastric cells reduced sensitivity drugs. Mechanistically, FAM117B competed nuclear factor E2–related 2 (NRF2) Kelch-like ECH-associated protein 1 (KEAP1) binding,...

10.1172/jci158705 article EN cc-by Journal of Clinical Investigation 2023-01-31

A number of neurotransmitters have been detected in tumor microenvironment and proved to modulate cancer oncogenesis progression. We previously found that biosynthesis secretion neurotransmitter 5-hydroxytryptamine (5-HT) was elevated colorectal cells. In this study, we discovered the HTR2B receptor 5-HT highly expressed tissues, which further identified as a strong risk factor for prognostic outcomes. Both pharmacological blocking genetic knocking down impaired migration cell, well...

10.1158/1541-7786.mcr-23-0513 article EN Molecular Cancer Research 2024-02-21

<div>Abstract<p>A number of neurotransmitters have been detected in tumor microenvironment and proved to modulate cancer oncogenesis progression. We previously found that biosynthesis secretion neurotransmitter 5-hydroxytryptamine (5-HT) was elevated colorectal cells. In this study, we discovered the HTR2B receptor 5-HT highly expressed tissues, which further identified as a strong risk factor for prognostic outcomes. Both pharmacological blocking genetic knocking down impaired...

10.1158/1541-7786.c.7267998 preprint EN 2024-06-04
Coming Soon ...